Product Name

  • Name

    Ketoconazole

  • EINECS 265-667-4
  • CAS No. 65277-42-1
  • Article Data12
  • CAS DataBase
  • Density 1.38 cm3
  • Solubility Soluble in DMSO, ethanol, chloroform, water, and methanol.
  • Melting Point 146 °C
  • Formula C26H28Cl2H4O4
  • Boiling Point 753.4 °C at 760 mmHg
  • Molecular Weight 531.439
  • Flash Point 409.4 °C
  • Transport Information UN 2811 6.1/PG 3
  • Appearance White powder
  • Safety 36-45-36/37/39-26
  • Risk Codes 25-36/37/38-23/24/25
  • Molecular Structure Molecular Structure of 65277-42-1 (Ketoconazole)
  • Hazard Symbols ToxicT
  • Synonyms Ketoconazole [USAN:BAN:INN:JAN];Ketoconazol [INN-Spanish];1-acetyl-4-(4-{[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine;Ketoconazole (JAN/USP);Nizoral (TN);KW-1414;(+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine;Nizoral;cis-1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1h-imidazol-1-ylmethyl)-1,3-diox olan- 4-yl)methoxy)phenyl)-piperazine;Prestwick_744;Fungarest;1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone;Fungoral;Ketoconazol;Piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-, cis-;Ketoderm;cis-1-Acetyl-4-[4-[2-(2,4-dichlorophenyl)-2-(1H-cmidazol-1-ylmethyl)-1,3-dioxolan-4-ylmethoxy]phenyl]pipenazine;
  • PSA 69.06000
  • LogP 4.20870

Synthetic route

1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanone
46503-52-0

1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanone

(+/-)-1-acetyl-4-<4-(2,3-dihydroxypropoxy)phenyl>piperazine

(+/-)-1-acetyl-4-<4-(2,3-dihydroxypropoxy)phenyl>piperazine

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
With trifluoroacetic acid In dimethyl sulfoxide; toluene for 16h; Reagent/catalyst; Temperature; Reflux;80%
1H-imidazole
288-32-4

1H-imidazole

(2R,4S)-cis-2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-<<4-(4-acetylpiperazin-1-yl)phenoxy>methyl>-1,3-dioxolane
142128-67-4

(2R,4S)-cis-2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-<<4-(4-acetylpiperazin-1-yl)phenoxy>methyl>-1,3-dioxolane

A

ketoconazole
65277-42-1

ketoconazole

B

(2R,4S)-cis-2-(hydroxymethyl)-2-(2,4-dichlorophenyl)-4-<<4-(4-acetylpiperazin-1-yl)phenoxy>methyl>-1,3-dioxolane
142004-25-9

(2R,4S)-cis-2-(hydroxymethyl)-2-(2,4-dichlorophenyl)-4-<<4-(4-acetylpiperazin-1-yl)phenoxy>methyl>-1,3-dioxolane

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl acetamide for 4h; Heating;A 53%
B 10%
(2R,4R)-(+)-<2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolan-4-yl>methyl methanesulfonate
170210-43-2

(2R,4R)-(+)-<2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolan-4-yl>methyl methanesulfonate

N-acetyl-N'-(4-hydroxyphenyl)piperazine
67914-60-7, 89929-31-7

N-acetyl-N'-(4-hydroxyphenyl)piperazine

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
With sodium hydride 1.) DMSO, RT, 1 h, 2.) DMSO, 80 deg C, 4 h; Yield given. Multistep reaction;
[cis-[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl] 4-methyl-benzenesulfonate

[cis-[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl] 4-methyl-benzenesulfonate

N-acetyl-N'-(4-hydroxyphenyl)piperazine
67914-60-7, 89929-31-7

N-acetyl-N'-(4-hydroxyphenyl)piperazine

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
With sodium hydride In dimethyl sulfoxide at 0 - 80℃;
1-(4-hydroxyphenyl)piperazine
56621-48-8

1-(4-hydroxyphenyl)piperazine

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: pyridine / CH2Cl2
2: K2CO3 / methanol / 20 °C
3: NaH / dimethylsulfoxide / 0 - 80 °C
View Scheme
1-(4-Acetoxyphenyl)-4-acetylpiperazine
133345-21-8

1-(4-Acetoxyphenyl)-4-acetylpiperazine

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3 / methanol / 20 °C
2: NaH / dimethylsulfoxide / 0 - 80 °C
View Scheme
(2R,4R)-(+)-<2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolan-4-yl>methyl benzoate
70894-66-5, 134071-29-7, 138866-89-4

(2R,4R)-(+)-<2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolan-4-yl>methyl benzoate

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: NaOH / dioxane / Heating
2: pyridine
3: NaH / dimethylsulfoxide / 0 - 80 °C
View Scheme
(2R,4S)-(+)-2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolane-4-methanol
170210-42-1

(2R,4S)-(+)-2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolane-4-methanol

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine
2: NaH / dimethylsulfoxide / 0 - 80 °C
View Scheme
Multi-step reaction with 2 steps
1: 81 percent / pyridine / 16 h / 0 °C
2: 1.) NaH / 1.) DMSO, RT, 1 h, 2.) DMSO, 80 deg C, 4 h
View Scheme
(2R,4R)-(+)-<2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolan-4-yl>methyl benzoate nitrate

(2R,4R)-(+)-<2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolan-4-yl>methyl benzoate nitrate

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 89 percent / 50percent aq. NaOH / dioxane / 0.5 h / Heating
2: 81 percent / pyridine / 16 h / 0 °C
3: 1.) NaH / 1.) DMSO, RT, 1 h, 2.) DMSO, 80 deg C, 4 h
View Scheme
1-(4-{4-[2-(2,4-dichloro-phenyl)-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-piperazin-1-yl)-ethanone
79156-75-5

1-(4-{4-[2-(2,4-dichloro-phenyl)-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-piperazin-1-yl)-ethanone

A

ketoconazole
65277-42-1

ketoconazole

B

(2R,4R)-Ketoconazole
142128-58-3

(2R,4R)-Ketoconazole

D

(2S,4S)-Ketoconazole
142128-60-7

(2S,4S)-Ketoconazole

Conditions
ConditionsYield
With methanol; sodium dodecyl-sulfate; 2,3,6-trimethyl-beta-cyclodextrin; sodium hydroxide In aq. phosphate buffer at 25℃; pH=2.5; pH-value; Reagent/catalyst; Temperature; Resolution of racemate;
Conditions
ConditionsYield
With Beckman P/ACE MDQ Capillary Electrophoresis System equipped fused-silica capillaries (Polymicro Technologies, Phoenix, Arizona) of 50-μm ID cut with sulfobutyl ether β-cyclodextrin as chiral selector In aq. buffer at 25℃; pH=2.5; Concentration; pH-value; Reagent/catalyst; Resolution of racemate;
N-acetyl-N'-(4-hydroxyphenyl)piperazine
67914-60-7, 89929-31-7

N-acetyl-N'-(4-hydroxyphenyl)piperazine

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide; tetrabutylammomium bromide / water; toluene / 16 h / 25 °C
2: trifluoroacetic acid / toluene; dimethyl sulfoxide / 16 h / Reflux
View Scheme
1,3-Dichlorobenzene
541-73-1

1,3-Dichlorobenzene

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: aluminum (III) chloride / dichloromethane / 0.5 h / 25 °C
1.2: 16 h / Reflux
2.1: triethylamine / dichloromethane / 10 °C
3.1: trifluoroacetic acid / toluene; dimethyl sulfoxide / 16 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1.1: aluminum (III) chloride / dichloromethane / 0.5 h / 25 °C
1.2: 16 h / Reflux
2.1: triethylamine / dichloromethane / 10 °C
3.1: trifluoroacetic acid / toluene; dimethyl sulfoxide / 16 h / Reflux
View Scheme
2,4-dichlorophenacyl bromide
2631-72-3

2,4-dichlorophenacyl bromide

ketoconazole
65277-42-1

ketoconazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dichloromethane / 10 °C
2: trifluoroacetic acid / toluene; dimethyl sulfoxide / 16 h / Reflux
View Scheme
Conditions
ConditionsYield
With cellulose (3,5-dimethylphenylcarbamate) coated reduced graphene oxide(at)silica gel In hexane at 25℃; Resolution of racemate; enantioselective reaction;
copper(II) acetate monohydrate
6046-93-1

copper(II) acetate monohydrate

ketoconazole
65277-42-1

ketoconazole

[Cu(ketoconazole)2(Ac)2]*H2O

[Cu(ketoconazole)2(Ac)2]*H2O

Conditions
ConditionsYield
In methanol at 25℃; for 24h;94%
copper(II) nitrate trihydrate

copper(II) nitrate trihydrate

ketoconazole
65277-42-1

ketoconazole

[Cu(ketoconazole)2(NO3)(H2O)](NO3)*H2O

[Cu(ketoconazole)2(NO3)(H2O)](NO3)*H2O

Conditions
ConditionsYield
In methanol at 25℃; for 36h;89%
zinc(II) nitrate hexahydrate

zinc(II) nitrate hexahydrate

ketoconazole
65277-42-1

ketoconazole

[Zn(ketoconazole)2(NO3)(H2O)](NO3)

[Zn(ketoconazole)2(NO3)(H2O)](NO3)

Conditions
ConditionsYield
In methanol at 25℃; for 24h;86%
bis(triphenylphosphino)copper(I) nitrate
14494-93-0, 23751-62-4, 106678-35-7

bis(triphenylphosphino)copper(I) nitrate

ketoconazole
65277-42-1

ketoconazole

[Cu(PPh3)2(cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine)2]NO3

[Cu(PPh3)2(cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine)2]NO3

Conditions
ConditionsYield
In acetonitrile for 24h;83%
potassium tetrachloroplatinate(II)
10025-99-7

potassium tetrachloroplatinate(II)

ketoconazole
65277-42-1

ketoconazole

trans-Pt(cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine)2Cl2

trans-Pt(cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine)2Cl2

Conditions
ConditionsYield
In ethanol; water at 100℃; for 2h;78%
methanol
67-56-1

methanol

ketoconazole
65277-42-1

ketoconazole

zinc(II) chloride
7646-85-7

zinc(II) chloride

[Zn(ketoconazole)2Cl2]*0.4CH3OH

[Zn(ketoconazole)2Cl2]*0.4CH3OH

Conditions
ConditionsYield
at 25℃; for 24h;78%
(tetrahydrothiophene)gold(I) chloride
39929-21-0

(tetrahydrothiophene)gold(I) chloride

ketoconazole
65277-42-1

ketoconazole

[Au(cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine)2]Cl

[Au(cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine)2]Cl

Conditions
ConditionsYield
In dichloromethane at 0℃; for 2h;65%
zinc(II) acetate dihydrate
5970-45-6

zinc(II) acetate dihydrate

ketoconazole
65277-42-1

ketoconazole

[Zn(ketoconazole)2(Ac)2]*H2O

[Zn(ketoconazole)2(Ac)2]*H2O

Conditions
ConditionsYield
In methanol at 25℃; for 24h;65%
Ethyl bromodifluoroacetate
667-27-6

Ethyl bromodifluoroacetate

ketoconazole
65277-42-1

ketoconazole

1-(4-(4-(((2R,4S)-2-(2,4-dichlorophenyl)-2-((3-(difluoromethyl)-2-thioxo-2,3-dihydro-1H-imidazol-1-yl)methyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethan-1-one

1-(4-(4-(((2R,4S)-2-(2,4-dichlorophenyl)-2-((3-(difluoromethyl)-2-thioxo-2,3-dihydro-1H-imidazol-1-yl)methyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethan-1-one

Conditions
ConditionsYield
With rongalite; sulfur In N,N-dimethyl acetamide at 100℃; for 24h; Sealed tube;43%
With sulfur; rongalite In N,N-dimethyl acetamide at 100℃; for 24h; Sealed tube;43%
ketoconazole
65277-42-1

ketoconazole

copper dichloride

copper dichloride

[Cu(ketoconazole)2Cl2]*3.2H2O

[Cu(ketoconazole)2Cl2]*3.2H2O

Conditions
ConditionsYield
In methanol at 25℃; for 0.5h;38%
ethyl bromofluoroacetate
401-55-8

ethyl bromofluoroacetate

ketoconazole
65277-42-1

ketoconazole

2-(3-(((2R,4S)-4-((4-(4-acetylpiperazin-1-yl)phenoxy)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)-2-thioxo-2,3-dihydro-1H-imidazol-1-yl)-2-fluoroacetic acid ethyl ester

2-(3-(((2R,4S)-4-((4-(4-acetylpiperazin-1-yl)phenoxy)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)-2-thioxo-2,3-dihydro-1H-imidazol-1-yl)-2-fluoroacetic acid ethyl ester

Conditions
ConditionsYield
With sulfur; sodium dithionite In 1,2-dichloro-ethane at 80℃; for 24h; Sealed tube;37%
With sulfur; sodium dithionite In 1,2-dichloro-ethane at 100℃; for 24h; Sealed tube;37%
ketoconazole
65277-42-1

ketoconazole

(+/-)-Deacylketoconazole

(+/-)-Deacylketoconazole

Conditions
ConditionsYield
With potassium hydroxide In isopropyl alcohol
With sodium hydroxide In methanol Reflux;700 mg
ketoconazole
65277-42-1

ketoconazole

ketoconazole-iodine

ketoconazole-iodine

Conditions
ConditionsYield
With iodine In 1,4-dioxane at 24.84 - 39.84℃; Kinetics; Equilibrium constant; Thermodynamic data; Solvent;
ketoconazole
65277-42-1

ketoconazole

2,4-diamino-6-piperidinopyrimidine 3-oxide
38304-91-5

2,4-diamino-6-piperidinopyrimidine 3-oxide

Ketoconazole Chemical Properties

Structure of Ketoconazole (CAS NO.65277-42-1):
 
Molecular Formula:C26H28Cl2N4O4
Molecular Weight:531.44
EINECS:265-667-4 
Index of Refraction: 1.642
Molar Refractivity: 139.11 cm3
Molar Volume: 384.9 cm3
Polarizability: 55.15×10-24cm3
Surface Tension: 52.1 dyne/cm
Density: 1.38 g/cm3
Flash Point: 409.4 °C
Enthalpy of Vaporization: 109.78 kJ/mol
Melting point: 146 oC
Boiling Point: 753.4 °C at 760 mmHg
Vapour Pressure: 1.39E-22 mmHg at 25 °C
Physical Appearance: White Powder
Product Categories: Active Pharmaceutical Ingredients;Organics;Antifungals for Research and Experimental Use;Antitumors for Research and Experimental Use;Biochemistry;Antibiotic Explorer;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API;API's;Antifungal

Ketoconazole History

 Ketoconazole was discovered in 1976 and released in 1981. It followed griseofulvin as one of the first available oral treatments for fungal infections.
 

Ketoconazole Uses

Usage of Ketoconazole (CAS NO.65277-42-1):
1.Inhibits cytochrome P-450 dependent steps in the biosynthesis of steroid hormones in vivo.
2.Antimetastatic and antineoplastic activity.
3.Orally active 5-lipoxygenase and thromboxane synthase inhibitor.

Ketoconazole Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
child TDLo oral 450mg/kg/90D- (450mg/kg) ENDOCRINE: EVIDENCE OF THYROID HYPOFUNCTION British Medical Journal. Vol. 293, Pg. 993, 1986.
dog LD50 intravenous 23300ug/kg (23.3mg/kg)   Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
dog LD50 oral 178mg/kg (178mg/kg)   Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
guinea pig LD50 intravenous 23300ug/kg (23.3mg/kg)   Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
guinea pig LD50 oral 178mg/kg (178mg/kg)   Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
man LDLo oral 45mg/kg/17D-I (45mg/kg) BEHAVIORAL: COMA

LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED"
Gut. Vol. 26, Pg. 636, 1986.
man TDLo oral 49mg/kg/17D-I (49mg/kg) LIVER: OTHER CHANGES Gastroenterology. Vol. 86, Pg. 503, 1984.
mouse LD50 intraperitoneal 2937mg/kg (2937mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 474, 1987.
mouse LD50 intravenous 32mg/kg (32mg/kg)   Antimicrobial Agents and Chemotherapy. Vol. 33, Pg. 895, 1989.
mouse LD50 oral 618mg/kg (618mg/kg)   Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
mouse LD50 subcutaneous > 4gm/kg (4000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 474, 1987.
rat LD50 intraperitoneal 1474mg/kg (1474mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 474, 1987.
rat LD50 intravenous 86mg/kg (86mg/kg)   Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 23, Pg. 1, 1982.
rat LD50 oral 166mg/kg (166mg/kg)   Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
rat LD50 subcutaneous > 2400mg/kg (2400mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 474, 1987.
women LDLo oral 264mg/kg/66D- (264mg/kg) LIVER: OTHER CHANGES Gastroenterology. Vol. 86, Pg. 503, 1984.
women LDLo oral 412mg/kg/15W- (412mg/kg) BEHAVIORAL: COMA

LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE"

LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED"
Gut. Vol. 26, Pg. 636, 1986.
women TDLo oral 60mg/kg (60mg/kg) LIVER: OTHER CHANGES Gastroenterology. Vol. 86, Pg. 503, 1984.
 

Ketoconazole Safety Profile

Hazard Codes: ToxicT
Risk Statements: 25-36/37/38-23/24/25 
R25 :Toxic if swallowed. 
R36/37/38:Irritating to eyes, respiratory system and skin. 
R23/24/25:Toxic by inhalation, in contact with skin and if swallowed.
Safety Statements: 36-45-36/37/39-26 
S36:Wear suitable protective clothing. 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) 
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection. 
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
RIDADR: UN 2811 6.1/PG 3
WGK Germany: 3
RTECS: TK7912300
HazardClass: 6.1(b)
PackingGroup: III
Poison by ingestion and intravenous routes. Experimental reproductive effects. Human systemic effects: liver changes, evidence of thyroid hypofunction. Human mutation data reported. Note: May be associated with hepatic toxicity. When heated to decomposition it emits toxic fumes of Cl and NOx.

Ketoconazole Specification

  Ketoconazole (CAS NO.65277-42-1), its Synonyms are (+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine ; Ketoconazolum ; Ketoderm ; Ketoisdin ; Ketozole ; Kuric ; Onofin K ; Orifungal M ; Panfungol .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View